REPLIGEN CORP
REPLIGEN CORP
Aktie · US7599161095 · RGEN · 870980 (XNAS)
Übersicht Finanzkennzahlen
131,52 USD
2,51 % 3,21 USD
NASDAQ (XNAS) · Aktuelle Kurse und Charts bei MoneyPeak
09.06.2025 17:09

Aktuelle Kurse von REPLIGEN CORP

BörseTickerWährungLetzter UmsatzKursTagesveränderung
XNAS: NASDAQ
NASDAQ
RGEN
USD
09.06.2025 17:09
131,52 USD
128,30 USD
+2,51 %

Performance

Heute Woche Monat 3 Monate 6 Monate 1 Jahr 5 Jahre
2,51 % 10,92 % 2,87 % -15,53 % -11,85 % -9,79 % 12,64 %

Firmenprofil zu REPLIGEN CORP Aktie

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and SpectraFlo dynamic dialysis systems; and ProConnex single-use hollow fiber. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Unternehmensdaten

Name REPLIGEN CORP
Firma Repligen Corporation
Symbol RGEN
Website https://www.repligen.com
Heimatbörse XNAS NASDAQ
WKN 870980
ISIN US7599161095
Wertpapierart Aktie
Sektor Healthcare
Branche Medical - Instruments & Supplies
CEO Mr. Olivier Loeillot
Marktkapitalisierung 7 Mrd.
Land Vereinigte Staaten von Amerika
Währung USD
Mitarbeiter 1,8 T
Adresse Building 1, 02453 Waltham
IPO Datum 1986-04-29

Ticker Symbole

Name Symbol
Frankfurt RGN.F
NASDAQ RGEN

Weitere Aktien

Investoren die REPLIGEN CORP die halten, haben auch folgende Aktien im Depot:
ACELRX PHARMACEUTICALS INC
ACELRX PHARMACEUTICALS INC Aktie
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Aktie
AMGEN INC
AMGEN INC Aktie
AUTODESK INC
AUTODESK INC Aktie
CISCO SYSTEMS INC
CISCO SYSTEMS INC Aktie
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Aktie
DEXCO INC
DEXCO INC Aktie
ERSTE GR.BK. 20/31 MTN
ERSTE GR.BK. 20/31 MTN Anleihe
INTUIT INC
INTUIT INC Aktie
MUNICIP.FIN. 22/27 MTN
MUNICIP.FIN. 22/27 MTN Anleihe
NOKIA CORP
NOKIA CORP Aktie
PROCTER GAMBLE CORP
PROCTER GAMBLE CORP Aktie
REGENERON PHARMACEUTICALS INC
REGENERON PHARMACEUTICALS INC Aktie
TEXAS INSTRUMENTS INC
TEXAS INSTRUMENTS INC Aktie
Die Finanzplattform MoneyPeak trackt und analysiert Investitionen und Portfolios. Vom Wertpapier-Depot bis zum Crypto-Kauf.
Nützlich, simpel und kostenlos. Aktien, ETF, ETC, ETN, Indizes, Fonds, Anleihen, Zertifikate, Währungen, Optionen, Bezugsrechte.
Impressum Datenschutz Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025